NCT03561233View on ClinicalTrials.gov

Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis

PHASE1CompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2018

Study Completion Date

June 30, 2018

Conditions
Systemic SclerosisGastroesophageal RefluxProton Pubm Inhibitor
Interventions
DRUG

Omeprazole 20mg

omeprazole 20 mg twice daily 30 minutes before meal for 4 weeks

All Listed Sponsors
collaborator

Thai Rheumatism Association

UNKNOWN

lead

Khon Kaen University

OTHER

NCT03561233 - Prevalence and Predictors of Proton Pump Inhibitor Partial Response in Gastroesophageal Reflux Disease in Systemic Sclerosis | Biotech Hunter | Biotech Hunter